Sun Pharma jumps 4% on robust Q3 results; brokerages maintain 'buy'

Shares of Sun Pharma jumped as much as 4.04 per cent to Rs 454.40 apiece in the early morning trade on BSE after the company reported a four-fold jump in its net profit for December quarter of financial year 2019 (FY19). 

The company posted net profit of Rs 1,241.85 crore against Rs 321.57 crore logged in the corresponding quarter of the previous fiscal. Consolidated revenue from operations of the company stood at Rs 7,740 crore, up 16 per cent as against Rs 6,653 crore for the same period year ago.

Maintaining a 'buy' call on the stock, brokerage Motilal Oswal